US Stock MarketDetailed Quotes
MBRX Moleculin Biotech
- 2.3900
- -0.0300-1.24%
Close Aug 23 16:00 ET
- 2.3900
- 0.00000.00%
Post 20:01 ET
6.80MMarket Cap-205P/E (TTM)
2.5500High2.2000Low30.03KVolume2.4500Open2.4200Pre Close71.22KTurnover1.09%Turnover RatioLossP/E (Static)2.84MShares15.750052wk High0.35P/B6.60MFloat Cap2.115052wk Low--Dividend TTM2.76MShs Float731.7000Historical High--Div YieldTTM14.46%Amplitude2.1150Historical Low2.3710Avg Price1Lot Size
About Moleculin Biotech Company
Moleculin Biotech, Inc. is a clinical stage pharmaceutical company. It engages in the business of growing a pipeline including phase 2 clinical programs for hard-to-treat cancers and viruses. The company was founded by Walter V. Klemp, Donald H. Picker, and Waldemar Priebe on July 28, 2015 and is headquartered in Houston, TX.
Company Profile
SymbolMBRX
Company NameMoleculin Biotech
Listing DateJun 2, 2016
Issue Price6.00
Founded2015
CEOMr. Walter V. Klemp
MarketNASDAQ
Employees18
Fiscal Year Ends12-31
Address5300 Memorial Drive,Suite 950
CityHouston
ProvinceTexas
CountryUnited States of America
Zip Code77007
Phone1-713-300-5160
Websitehttp://www.moleculin.com
Company Executives
- Name
- Position
- Salary
- Walter V. Klemp
- Chairman of the Board, President and Chief Executive Officer
- 1.41M
- Jonathan P. Foster
- Chief Financial Officer, Executive Vice President and Principal Accounting Officer
- 840.64K
- Dr. Donald H. Picker, PhD
- Chief Scientific Officer
- 599.11K
- Michael D. Cannon
- Independent Director
- 68.52K
- Dr. Joy Yan, M.D.,PhD
- Independent Director
- 47.15K
- Robert E. George
- Independent Director
- 74.90K
- Elizabeth A. Cermak
- Independent Director
- 63.52K
- John M. Climaco, Esq.
- Lead Independent Director
- 81.05K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg